Search results
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
Zacks via Yahoo Finance· 18 hours agoIntra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 7 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
Zacks via Yahoo Finance· 21 hours agoIts revenues have jumped from $28.3 billion in 2021 to $34.1 billion in 2023. Conclusion While other...
Searching for Data on Black Patients and Long Covid
Bloomberg· 2 days agoHave a confidential tip for our reporters? On this Juneteenth, when the US celebrates Black history and freedom, I want to talk about an interesting ...
Gateway - Quartz
Quartz· 2 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1 bird flu vaccine, as the virus continues to spread rapidly among poultry ...
Gateway - Quartz
Quartz· 3 days agoA new study found that Novo Nordisk’s nearly $1,000 per month diabetes medication Ozempic can be produced for less than $5 a month. Novo Nordisk and Johnson & Johnson both announced billion-dollar ...
Gateway - Quartz
Quartz· 3 days agoHealthcare companies including Ro and Eli Lilly are introducing online supply trackers to help patients navigate ongoing GLP-1 drug shortages. Moderna says it is in talks ...
Personalis CFO and COO Aaron Tachibana sells shares worth $9.3k By Investing.com
Investing.com· 13 hours agoPersonalis, Inc. (NASDAQ:PSNL) reported that its Chief Financial Officer and Chief Operating...
Personalis Inc. executive sells over $6,500 in company stock By Investing.com
Investing.com· 13 hours agoPersonalis, Inc. (NASDAQ:PSNL) has reported a recent transaction by Chief Medical Officer and EVP,...
Gateway - Quartz
Quartz· 3 days agoNovo Nordisk responded this week to the Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and raise prices. Moderna stock surged ...